There now is new hope for patients suffering from Fatty Liver Disease. A natural product called BergaMet™, an extract from a citrus fruit grown only on the west coast of Italy, has recently been proven effective for patients with non-alcoholic fatty liver disease (NAFLD).
Two separate studies conducted in Italy confirmed these findings. This highly concentrated proprietary extract of the Calabrian bergamot fruit (38% citrus bergamot extract, BergaMet™) powerfully benefits patients with nonalcoholic fatty liver disease (NAFLD). We knew from previous research that BergaMet™ was very effective in lowering cholesterol and was a metabolic regulator that routinely improves vascular health.
In one study, Dr. James Ehrlich of the University of Colorado concluded that this “exciting new area of research” suggests an important additional indication for BergaMet™ that could improve the lives of millions. “BergaMet™ may be the most versatile and important natural supplement ever developed. We have been impressed by its safety and its clinical value for individuals with conditions ranging from metabolic syndrome to high cholesterol to statin intolerance and obesity. The present investigations show great promise that hepatic steatosis (NAFLD), a highly prevalent and important condition can finally be effectively addressed by a safe commercially available product.”
The study conducted by Professor G. Rosano, from San Raffaelle Pisana Clinic, Rome, which involved investigators from the US, Australia and the University of Catanzaro led by Professor V. Mollace, 107 patients with metabolic syndrome and NAFLD were treated for 120 days with polyphenol-rich 38% citrus bergamot extract (BergaMet™). They found significant improvements in cholesterol levels, lipid particle characteristics, blood sugar and inflammation. Moreover, there was a strikingly positive effect on both liver function and structure.
Serial ultrasounds of the liver revealed a dramatic 50% reduction in liver fat, while biochemical analysis (“steato test”) demonstrated a 40% improvement in lifer function tests. Bergamot therapy converted the typical patient from severe fatty liver to the moderate category in 12 weeks. Standard liver function blood tests also quickly normalized in the majority of patients.
Professor Vincenzo Mollace of the University of Catanzaro noted “our studies in both rats and humans have consistently demonstrated that therapy with bergamot counters the accumulation of fat in the liver while completely prompting its elimination.”
In a second separate study, a group of investigators led by Professor F. Andreozzi (Polyclinico Umberto I, Rome) gave bergamot extract plus oleo European and ascorbic acid to 40 patients with fatty liver disease for a period of 60 days. As previously shown, the study demonstrated significant improvements in lipid levels, insulin resistance, visceral fat/waist circumference and endothelial health (vascular function). In addition, highly significant improvements in liver function tests were demonstrated in this study.
These new findings are very important for those who suffer from NAFLD. Due to the accelerated incidence of obesity in the United States, and the World, nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver abnormality, now exceeding the incidence of cirrhosis from excess alcohol intake. In fact, NAFLD is the number one reason for liver transplants now.
This increased incidence of NAFLD in Western countries (20-30%) parallels the epidemic of metabolic syndrome (a triad of obesity, high blood pressure and high triglycerides), obesity and diabetes. NAFLD frequently is disabling and occasionally can lead to cirrhosis. In the past, fatty liver disease has been difficult to treat. Vitamin E is anti-oxidant that is helpful in a minority of patients, but very few natural and safe supplements are available that might ameliorate the condition, decrease hepatic fat and improve liver function abnormalities.
These finding are exciting and a ray of hope for those suffering from NAFLD. In addition to its effects on lowering and lipid particle size, BergaMet can help reduce many conditions associated with the overweight condition. BergaMet should be taken twice daily, 20 to 30 minutes before the two largest meals of the day for the best effect. It is especially helpful for those patients who do not tolerate statins. It is the “natural” way to combat the cholesterol problems, and now NAFL problems. Call our office for further information on this product, or go to www.bergamet.com.